{
  "id": "Haemorr2hages.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2016-01-26",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "other_contributors": [
      "Dennis Forslund",
      "Jimmy Axelsson",
	  "Daniel Keszthelyi"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "sv": {
        "id": "sv",
        "purpose": "Att utvärdera blödningsrisk bland äldre patienter med förmaksflimmer.",
        "keywords": [
          "blödning",
          "blödningsrisk",
          "Hemorr2hages",
          "kardiologi"
        ],
        "use": "HEMORR2HAGES score används för att utvärdera blödningsrisk hos patienter med antikoagulantia-behandlat förmaksflimmer. \r\n\r\nInstrumentet kombinerar faktorer från flertalet validerade verktyg för uppskattning av blödningsrisk, och baseras på totalt elva faktorer. Total poäng uppgår till maximalt 12p, och resultatet tolkas enligt:\r\n\r\n1p – blödningsrisk 2,5% per 100 patientår med warfarin. Risken anses tillräckligt låg för att patienten ska kunna fortsätta behandlingen.\r\n2p – blödningsrisk 5,3% per 100 patientår med warfarin. Alternativ behandling bör övervägas.\r\n≥4p – alternativ behandling rekommenderas.\r\n",
        "misuse": "Användning av detta instrument bör kompletteras med andra validerade riskskalor och utförlig riskvärdering av den individuella patienten.",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "id": "en",
        "purpose": "Helps to assess the risk of haemorrhage among elderly patients who have Atrial Fibrillation.",
        "keywords": [
          "haemorrhage",
          "major bleeding risk",
          "Hemorr2hages",
          "cardiology"
        ],
        "use": "The HEMORR2HAGES score is used to assess and divide patients in terms of risk of bleeding after anticoagulation for atrial fibrillation.\n\nThis scoring tool pulls together elements from a number of other validated bleeding risk scores.\n\nThere are a series of 11 questions all scored between 0 and 1 apart from the question related to history of past bleeding which ranges from 0 to 2. The total summed score of each part ranges from 0 to 12.\n\nA score of 1 relates to a bleeding risk of 2.5% per 100 patient-years of warfarin and is seen a of low enough risk to allow the patient to continue with anticoagulation.\n\nJust 2 points (5.3% risk) is enough to caution the use of anticoagulation and scores of 4 and above should routinely trigger finding alternatives to anticoagulation on these patients.",
        "misuse": "This tool should be accompanied by the use of other validated bleeding risk scores, and a thorough risk/benefit analysis of anticoagulation should be considered in respect to all patients before initiating therapy in case alternative options are deemed more appropriate.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "other_details": {
      "references": "Ref. 1: Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation. Am Heart J 2006; 151:713-9.\r\nValidation\r\n\r\nRef. 2: Stavros Apostolakis, MD, PhD, Deirdre A. Lane, PhD, Yutao Guo, MD, Harry Buller, MD, PhD, Gregory Y.H. Lip, MD Performance of the HEMORR\r\nOther References"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "template_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          }
        }
      },
      "gt0005": {
        "id": "gt0005",
        "model_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "template_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          }
        }
      },
      "gt0007": {
        "id": "gt0007",
        "model_id": "openEHR-EHR-OBSERVATION.haemorr2hages_score_for_major_bleeding_risk.v1",
        "template_id": "openEHR-EHR-OBSERVATION.haemorr2hages_score_for_major_bleeding_risk.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0033": {
            "id": "gt0033",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0015]"
          }
        }
      },
      "gt0020": {
        "id": "gt0020",
        "model_id": "openEHR-EHR-OBSERVATION.haemorr2hages_score_for_major_bleeding_risk.v1",
        "template_id": "openEHR-EHR-OBSERVATION.haemorr2hages_score_for_major_bleeding_risk.v1",
        "type": "INPUT",
        "elements": {
          "gt0021": {
            "id": "gt0021",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0022": {
            "id": "gt0022",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0005]"
          },
          "gt0023": {
            "id": "gt0023",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0006]"
          },
          "gt0025": {
            "id": "gt0025",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0026": {
            "id": "gt0026",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0009]"
          },
          "gt0027": {
            "id": "gt0027",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0028": {
            "id": "gt0028",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0011]"
          },
          "gt0029": {
            "id": "gt0029",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0012]"
          },
          "gt0030": {
            "id": "gt0030",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0031": {
            "id": "gt0031",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0014]"
          }
        }
      }
    },
    "rules": {
      "gt0037": {
        "id": "gt0037",
        "priority": 4,
        "when": [
          "$gt0003|Birthdate|!=null"
        ],
        "then": [
          "$gt0006|Age|.magnitude=$currentDateTime.year-$gt0003.year",
          "$gt0006|Age|.unit='a'"
        ]
      },
      "gt0038": {
        "id": "gt0038",
        "priority": 3,
        "when": [
          "$gt0006|Age|.unit=='a'",
          "$gt0006|Age|.magnitude>75",
          "fired($gt0037)"
        ],
        "then": [
          "$gt0011|Age > 75 yrs|=1|local::at0024|Yes|"
        ]
      },
      "gt0039": {
        "id": "gt0039",
        "priority": 2,
        "when": [
          "$gt0006|Age|.unit=='a'",
          "$gt0006|Age|.magnitude<=75",
          "fired($gt0037)"
        ],
        "then": [
          "$gt0011|Age > 75 yrs|=0|local::at0023|No|"
        ]
      },
      "gt0047": {
        "id": "gt0047",
        "priority": 1,
        "when": [
          "$gt0011|Age > 75 yrs|!=null",
          "$gt0021|Hepatic or renal disease|!=null",
          "$gt0022|Ethanol (alcohol) abuse|!=null",
          "$gt0023|Malignancy History|!=null",
          "$gt0025|Reduced Platelet count/function|!=null",
          "$gt0026|History of past bleeding|!=null",
          "$gt0027|Hypertension (uncontrolled)|!=null",
          "$gt0028|Anaemia|!=null",
          "$gt0029|Genetic factors|!=null",
          "$gt0030|Excessive fall risk|!=null",
          "$gt0031|Stroke History|!=null"
        ],
        "then": [
          "$gt0033|Total score|.magnitude=$gt0021.value+$gt0022.value+$gt0023.value+$gt0025.value+$gt0026.value+$gt0027.value+$gt0028.value+$gt0029.value+$gt0030.value+$gt0031.value+$gt0011.value"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "sv": {
        "id": "sv",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Hemorr2hages Score",
            "description": "HEMORR2HAGES Score används för att utvärdera risk för blödning hos patienter med antikoagulantia-behandlat förmaksflimmer. \r\n"
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Födelsedatum",
            "description": "*(en) *"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Ålder",
            "description": "*(en) Age in years, and for babies: months, weeks or days"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Ålder > 75 år",
            "description": "*(en) *"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Lever- eller njursjukdom",
            "description": "*(en) *"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Alkoholmissbruk",
            "description": "*(en) *"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Cancerhistorik",
            "description": "*(en) *"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Trombocytopeni",
            "description": "*(en) Includes aspirin use, any thrombocytopenia or blood dyscrasia, like hemophilia"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Tidigare blödning",
            "description": "*(en) *"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Hypertoni (okontrollerad)",
            "description": "*(en) *"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Anemi",
            "description": "*(en) Hgb <13 g/dL for Men; Hgb <12 g/dL for Women"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Genetiska faktorer",
            "description": "*(en) CYP 2C9 single-nucleotide polymorphisms"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Hög fallrisk",
            "description": "*(en) *"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Tidigare stroke",
            "description": "*(en) *"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "Resultat",
            "description": "*(en) Sum of individual scores"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "Beräkna ålder"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "CDS ålder > 75 år"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "CDS ålder <= 75 år"
          },
          "gt0047": {
            "id": "gt0047",
            "text": "Beräkna resultat"
          }
        }
      },
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Hemorr2hages Score",
            "description": "The HEMORR2HAGES score is used to assess and divide patients in terms of risk of bleeding after anticoagulation for atrial fibrillation."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Birthdate",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Age",
            "description": "Age in years, and for babies: months, weeks or days"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Age > 75 yrs",
            "description": "*"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Hepatic or renal disease",
            "description": "*"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Ethanol (alcohol) abuse",
            "description": "*"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Malignancy History",
            "description": "*"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Reduced Platelet count/function",
            "description": "Includes aspirin use, any thrombocytopenia or blood dyscrasia, like hemophilia"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "History of past bleeding",
            "description": "*"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Hypertension (uncontrolled)",
            "description": "*"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Anaemia",
            "description": "Hgb <13 g/dL for Men; Hgb <12 g/dL for Women"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Genetic factors",
            "description": "CYP 2C9 single-nucleotide polymorphisms"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Excessive fall risk",
            "description": "*"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Stroke History",
            "description": "*"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "Total score",
            "description": "Sum of individual scores"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "Calc age"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "Set Age > 75 yrs"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "Set Age <= 75"
          },
          "gt0047": {
            "id": "gt0047",
            "text": "Calculate total score"
          }
        }
      }
    }
  }
}